by British Medical Journal Credit: Pixabay/CC0 Public DomainThe common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the five to 10 years preceding the start of symptoms, according to research published in the open access journal RMD Open. The risks seem to be greatest for...
WILEY Among U.S. patients with rheumatic disease and COVID-19, racial/ethnic minorities had higher risks of needing to be hospitalized and put on ventilators. The findings come from an analysis published in Arthritis & Rheumatology. The analysis included data on all U.S. patients with rheumatic disease and COVID-19 entered into the COVID-19 Global Rheumatology Alliance physician registry...
Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research UNIVERSITY OF LEEDS Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research. Having rheumatoid arthritis (RA) is known to at least double...
CLEVELAND–Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for...
by Karolinska Institutet A novel study from the Institute of Environmental Medicine at Karolinska Institutet indicates that antibodies against a small lipid entity, phosphorylcholine (PC), can be associated with protection in inflammatory systemic diseases, including SLE and Sjögren’s syndrome. The results support evidence for a potential treatment by providing antibodies (anti-PC) to patients with these...
by Delthia Ricks , Medical Xpress Many rheumatic conditions develop slowly and initially have inflammatory arthritis as the first sign that something is amiss. The trouble with such close similarity is the difficulty that clinicians have differentiating one condition from another in the early stages of the disease process. Dr. Rachel Knevel and colleagues at...
A European League Against Rheumatism (EULAR) database containing information on the effects of COVID-19 on patients with rheumatic and musculoskeletal diseases has given some reassurance to patients taking immunosuppressants. The drugs studied by the team include anti-malarial drugs, methotrexate, biological therapies such as TNF-alpha inhibitors, and nonsteroidal anti-inflammatory drugs such as Naproxen. None of them...
by European League Against Rheumatism (EULAR) The current outbreak of COVID-19 represents a source of concern for the management of systemic lupus erythematous, SLE, patients. These patients have an increased risk of severe infections due to their underlying disease, the use of immunosuppressive drugs, as well as the potential presence of organ damage associated with...
(HealthDay)—The Coronary Calcium Score (CCS) may be a useful tool in cardiovascular (CV) risk assessment among female patients with rheumatoid arthritis (RA), according to a study published in the October issue of the International Journal of Rheumatic Diseases. Miguel Bernardes, M.D., from the University of Porto in Portugal, and colleagues assessed CCS (using computed tomography)...
